** Shares of Kleenex tissue maker Kimberly-Clark KMB.N down ~2% at $125.25 premarket
** Brokerage TD Cowen lowers rating to "hold" from "buy", cuts PT to $145 from $159
** Brokerage expects gross margin expansion in 2025 to slow down as benefits from commodity cost deflation in pulp and paper are beginning to reverse
** External factors like hurricanes, shifts in trade inventory, slowdown in professional market seem to be impacting KMB's organic growth more profoundly than its peers - brokerage
** Six of 20 brokerages rate the stock "buy" or "higher", 12 "hold" and two "sell" or "lower"; median PT is $150 - LSEG
** KMB rose about 8% in 2024
(Reporting by Anuja Bharat Mistry in Bengaluru)
((AnujaBharat.Mistry@thomsonreuters.com;))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。